60 related articles for article (PubMed ID: 6234689)
1. Cell-mediated hyperacute rejection. V. Cessation of transfer effectiveness.
Eichwald EJ; Jorgensen C
Transplantation; 1984 Jul; 38(1):86-7. PubMed ID: 6234689
[No Abstract] [Full Text] [Related]
2. Cell-mediated hyperacute rejection. VIII. The recipient's role in adoptive transfer.
Eichwald EJ; Bernhard EJ; Jorgensen C
Transplantation; 1985 Feb; 39(2):219-20. PubMed ID: 3871543
[No Abstract] [Full Text] [Related]
3. Cell-mediated hyperacute rejection. IV. Lyt markers and adoptive transfer.
Eichwald EJ; Jorgensen C; Graves G
J Immunol; 1982 May; 128(5):2373-4. PubMed ID: 6977593
[No Abstract] [Full Text] [Related]
4. Cell-mediated hyperacute rejection. VII. Suppression by irradiation.
Eichwald EJ; Jorgensen C
Transplantation; 1984 Aug; 38(2):191-2. PubMed ID: 6380046
[No Abstract] [Full Text] [Related]
5. Adoptive transfer of double negative T regulatory cells induces B-cell death in vivo and alters rejection pattern of rat-to-mouse heart transplantation.
Ma Y; He KM; Garcia B; Min W; Jevnikar A; Zhang ZX
Xenotransplantation; 2008 Feb; 15(1):56-63. PubMed ID: 18333914
[TBL] [Abstract][Full Text] [Related]
6. Immune mechanisms in organ allograft rejection.
Lowry RP; Gurley KE; Forbes RD
Transplant Proc; 1982 Dec; 14(4):679-81. PubMed ID: 6220495
[No Abstract] [Full Text] [Related]
7. In vitro growth of murine T cells. VI. Accelerated skin graft rejection caused by adoptively transferred cells expanded in T cell growth factor.
Rosenstein M; Eberlein T; Kemeny MM; Sugarbaker PH; Rosenberg SA
J Immunol; 1981 Aug; 127(2):566-71. PubMed ID: 7019327
[TBL] [Abstract][Full Text] [Related]
8. Transfer of cell-mediated hyperacute rejection reaction. The role of active sensitization.
Emam M; Barstad R; Eichwald EJ
Cell Immunol; 1980 Feb; 49(2):426-31. PubMed ID: 6986205
[No Abstract] [Full Text] [Related]
9. Cellular basis of passive enhancement of graft survival.
Pearce NW; Dorsch SE; Hall BM
Transplant Proc; 1988 Feb; 20(1):53-5. PubMed ID: 2964113
[No Abstract] [Full Text] [Related]
10. In vivo methods for the assessment of cell-mediated tumor immunity.
Bartlett GL
Natl Cancer Inst Monogr; 1972 Dec; 35():27-32. PubMed ID: 4659049
[No Abstract] [Full Text] [Related]
11. Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy.
Feng G; Wood KJ; Bushell A
Transplantation; 2008 Aug; 86(4):578-89. PubMed ID: 18724229
[TBL] [Abstract][Full Text] [Related]
12. Impaired antigen presentation and effectiveness of combined active/passive immunotherapy for epithelial tumors.
Matsumoto K; Leggatt GR; Zhong J; Liu X; de Kluyver RL; Peters T; Fernando GJ; Liem A; Lambert PF; Frazer IH
J Natl Cancer Inst; 2004 Nov; 96(21):1611-9. PubMed ID: 15523090
[TBL] [Abstract][Full Text] [Related]
13. Thymocyte/splenocyte-derived CD4+CD25+Treg stimulated by anti-CD200R2 derived dendritic cells suppress mixed leukocyte cultures and skin graft rejection.
Gorczynski RM
Transplantation; 2006 Apr; 81(7):1027-34. PubMed ID: 16612280
[TBL] [Abstract][Full Text] [Related]
14. Effect of T-cell transfer on Pneumocystis carinii infection in nude mice.
Furuta T; Ueda K; Kyuwa S; Fujiwara K
Jpn J Exp Med; 1984 Apr; 54(2):57-64. PubMed ID: 6332219
[TBL] [Abstract][Full Text] [Related]
15. Gamma delta T cells in normal spleen assist immunized alpha beta T cells in the adoptive cell transfer of contact sensitivity. Effect of Bordetella pertussis, cyclophosphamide, and antibodies to determinants on suppressor cells.
Askenase PW; Szczepanik M; Ptak M; Paliwal V; Ptak W
J Immunol; 1995 Apr; 154(8):3644-53. PubMed ID: 7706708
[TBL] [Abstract][Full Text] [Related]
16. Alloantigen-specific prolongation of allograft survival in recipient mice treated by alloantigen immunization following ultraviolet-B irradiation.
Hori T; Kuribayashi K; Uemoto S; Saito K; Wang L; Torii M; Shibutani S; Taniguchi K; Yagi S; Iida T; Yamamoto C; Kato T
Transpl Immunol; 2008 Apr; 19(1):45-54. PubMed ID: 18346637
[TBL] [Abstract][Full Text] [Related]
17. [Cell-mediated immunity in mice infected with Japanese encephalitis virus. II. Passive transfer of immune spleen T cells for life protection in infected mice].
Jia FL; Huang ZX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Feb; 5(1):68-9. PubMed ID: 6313237
[No Abstract] [Full Text] [Related]
18. Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice.
Lee MK; Huang X; Jarrett BP; Moore DJ; Desai NM; Moh Lian M; Markmann JW; Deng S; Frank A; Singer A; Velidedeoglu E; Caton AJ; Markmann AJ
Transplantation; 2003 Apr; 75(8):1415-22. PubMed ID: 12717241
[TBL] [Abstract][Full Text] [Related]
19. CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection.
Steger U; Kingsley CI; Karim M; Bushell AR; Wood KJ
Transplantation; 2006 Nov; 82(9):1202-9. PubMed ID: 17102772
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated immunity in hyperacute kidney rejection: tests for detecting presensitization.
Thomas FT; Thomas JM; Fawley JC; Volk M; Burke SG; Wolf JS; Lee HM
Surg Forum; 1974; 25(0):270-3. PubMed ID: 4612774
[No Abstract] [Full Text] [Related]
[Next] [New Search]
